Terms: = Colorectal cancer AND BMPR1A, ACVRLK3, 657, ENSG00000107779, P36894, ALK3, CD292 AND Prognosis
22 results:
1. Lymph node ratio and hematological parameters predict relapse-free survival in patients with high grade rectal neuroendocrine neoplasms after radical resection: a multicenter prognostic study.
Zeng X; Zhang P; Zhu G; Li C; Zhang R; Yu M; Lin G; Di M; Jiang C; Li Y; Sun Y; Xia L; Chi P; Tao K
World J Surg Oncol; 2023 Sep; 21(1):300. PubMed ID: 37736728
[TBL] [Abstract] [Full Text] [Related]
2. PTPN9 dephosphorylates FGFR2 pY656/657 through interaction with ACAP1 and ameliorates pemigatinib effect in cholangiocarcinoma.
Zhao L; Liu J; Li K; Zhang C; Chen T; Liu Z; Tang Y; Hu X; Shi A; Shu L; Huang S; Lian S; Zhang M; Li H; Sun J; Yu X; Zhang Z; Zhang Z; Xu Y
Hepatology; 2024 Apr; 79(4):798-812. PubMed ID: 37505213
[TBL] [Abstract] [Full Text] [Related]
3. The Effect of RAS/BRAF Mutation Status on prognosis and Relapse Pattern in Early Stage Colon cancers.
Kunt N; Araz M; Yildirim MS; Findik S; Kocak MZ; Eryilmaz MK; Artac M
J Gastrointest Cancer; 2023 Dec; 54(4):1316-1321. PubMed ID: 37191843
[TBL] [Abstract] [Full Text] [Related]
4. Long-term outcomes after endoscopic versus surgical resection of T1 colorectal carcinoma.
Bae HJ; Ju H; Lee HH; Kim J; Lee BI; Lee SH; Won DD; Lee YS; Lee IK; Cho YS
Surg Endosc; 2023 Feb; 37(2):1231-1241. PubMed ID: 36171453
[TBL] [Abstract] [Full Text] [Related]
5. Current cancer burden in China: epidemiology, etiology, and prevention.
Maomao C; He L; Dianqin S; Siyi H; Xinxin Y; Fan Y; Shaoli Z; Changfa X; Lin L; Ji P; Wanqing C
Cancer Biol Med; 2022 Aug; 19(8):1121-38. PubMed ID: 36069534
[TBL] [Abstract] [Full Text] [Related]
6. Serum macrophage inhibitory cytokine-1 serves as a novel diagnostic biomarker of early-stage colorectal cancer.
Dai C; Zhang X; Ma Y; Chen Z; Chen S; Zhang Y; Li M
Biomarkers; 2021 Nov; 26(7):598-605. PubMed ID: 34266319
[TBL] [Abstract] [Full Text] [Related]
7. Validation of the Colon Life nomogram in patients with refractory metastatic colorectal cancer enrolled in the RECOURSE trial.
Pietrantonio F; Fucà G; Manca P; Pagani F; Raimondi A; Prisciandaro M; Randon G; Corti F; de Braud F; Cremolini C; Miceli R
Tumori; 2021 Aug; 107(4):353-359. PubMed ID: 33021466
[TBL] [Abstract] [Full Text] [Related]
8. Organoid cultures of early-onset colorectal cancers reveal distinct and rare genetic profiles.
Yan HHN; Siu HC; Ho SL; Yue SSK; Gao Y; Tsui WY; Chan D; Chan AS; Wong JWH; Man AHY; Lee BCH; Chan ASY; Chan AKW; Hui HS; Cheung AKL; Law WL; Lo OSH; Yuen ST; Clevers H; Leung SY
Gut; 2020 Dec; 69(12):2165-2179. PubMed ID: 32217638
[TBL] [Abstract] [Full Text] [Related]
9. Genetic Predictors of Circulating 25-Hydroxyvitamin D and prognosis after colorectal cancer.
Neumeyer S; Butterbach K; Banbury BL; Berndt SI; Campbell PT; Chlebowski RT; Chan AT; Giovannucci EL; Joshi AD; Ogino S; Song M; McCullough ML; Maalmi H; Manson JE; Sakoda LC; Schoen RE; Slattery ML; White E; Win AK; Figueiredo JC; Hopper JL; Macrae FA; Peters U; Brenner H; Hoffmeister M; Newcomb PA; Chang-Claude J
Cancer Epidemiol Biomarkers Prev; 2020 Jun; 29(6):1128-1134. PubMed ID: 32188599
[TBL] [Abstract] [Full Text] [Related]
10. Novel Multiple miRNA-Based Signatures for Predicting Overall Survival and Recurrence-Free Survival of colorectal cancer Patients.
Qian J; Zeng L; Jiang X; Zhang Z; Luo X
Med Sci Monit; 2019 Sep; 25():7258-7271. PubMed ID: 31560680
[TBL] [Abstract] [Full Text] [Related]
11. Predictive and prognostic implications of 4E-BP1, Beclin-1, and LC3 for cetuximab treatment combined with chemotherapy in advanced colorectal cancer with wild-type KRAS: Analysis from real-world data.
Guo GF; Wang YX; Zhang YJ; Chen XX; Lu JB; Wang HH; Jiang C; Qiu HQ; Xia LP
World J Gastroenterol; 2019 Apr; 25(15):1840-1853. PubMed ID: 31057298
[TBL] [Abstract] [Full Text] [Related]
12. [Prognostic factors of patients with unresectable liver metastasis from colorectal cancer after failed conversion chemotherapy].
He H; Shen W; Chen W; Liu H; Gong W; Fu J; Hu X; Cui L
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Nov; 21(11):1261-1267. PubMed ID: 30506537
[TBL] [Abstract] [Full Text] [Related]
13. Prognostic and clinical significance of claudin-1 in colorectal cancer: A systemic review and meta-analysis.
Jiang L; Yang L; Huang H; Liu BY; Zu G
Int J Surg; 2017 Mar; 39():214-220. PubMed ID: 28192244
[TBL] [Abstract] [Full Text] [Related]
14. Baseline mortality-adjusted survival in colon cancer patients.
Ukegjini K; Zadnikar M; Warschkow R; Müller S; Schmied BM; Marti L
Langenbecks Arch Surg; 2016 Aug; 401(5):633-41. PubMed ID: 27102323
[TBL] [Abstract] [Full Text] [Related]
15. OX40 expression enhances the prognostic significance of CD8 positive lymphocyte infiltration in colorectal cancer.
Weixler B; Cremonesi E; Sorge R; Muraro MG; Delko T; Nebiker CA; Däster S; Governa V; Amicarella F; Soysal SD; Kettelhack C; von Holzen UW; Eppenberger-Castori S; Spagnoli GC; Oertli D; Iezzi G; Terracciano L; Tornillo L; Sconocchia G; Droeser RA
Oncotarget; 2015 Nov; 6(35):37588-99. PubMed ID: 26439988
[TBL] [Abstract] [Full Text] [Related]
16. Loss of SMAD4 alters BMP signaling to promote colorectal cancer cell metastasis via activation of Rho and ROCK.
Voorneveld PW; Kodach LL; Jacobs RJ; Liv N; Zonnevylle AC; Hoogenboom JP; Biemond I; Verspaget HW; Hommes DW; de Rooij K; van Noesel CJ; Morreau H; van Wezel T; Offerhaus GJ; van den Brink GR; Peppelenbosch MP; Ten Dijke P; Hardwick JC
Gastroenterology; 2014 Jul; 147(1):196-208.e13. PubMed ID: 24704720
[TBL] [Abstract] [Full Text] [Related]
17. Lymph node evaluation in stage IIA colorectal cancer and its impact on patient prognosis: a population-based study.
Iachetta F; Reggiani Bonetti L; Marcheselli L; Di Gregorio C; Cirilli C; Messinese S; Cervo GL; Postiglione R; Di Emidio K; Pedroni M; Longinotti E; Federico M; Ponz de Leon M
Acta Oncol; 2013 Nov; 52(8):1682-90. PubMed ID: 23786176
[TBL] [Abstract] [Full Text] [Related]
18. Norms of vagal nerve activity, indexed by Heart Rate Variability, in cancer patients.
De Couck M; Gidron Y
Cancer Epidemiol; 2013 Oct; 37(5):737-41. PubMed ID: 23725879
[TBL] [Abstract] [Full Text] [Related]
19. colorectal cancer in inflammatory bowel diseases: a population-based study (1976-2008).
Peyrin-Biroulet L; Lepage C; Jooste V; Guéant JL; Faivre J; Bouvier AM
Inflamm Bowel Dis; 2012 Dec; 18(12):2247-51. PubMed ID: 22467511
[TBL] [Abstract] [Full Text] [Related]
20. Increased expression of ubiquitin-specific protease 22 can promote cancer progression and predict therapy failure in human colorectal cancer.
Liu YL; Yang YM; Xu H; Dong XS
J Gastroenterol Hepatol; 2010 Nov; 25(11):1800-5. PubMed ID: 21039844
[TBL] [Abstract] [Full Text] [Related]
[Next]
